兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06622 兆科眼科-B

未开盘 02-04 16:00:00

3.240

-0.200

-5.81%

最高3.460	最低3.230	成交量113.10万
今开3.430	昨收3.440	日振幅6.69%
总市值17.76亿	流通市值17.76亿	总股本5.48亿
成交额374.34万	换手率0.21%	流通股本5.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"兆科眼科-B","latestPrice":3.24,"timestamp":1770192000017,"preClose":3.44,"halted":0,"volume":1131000,"delay":0,"changeRate":-0.05813953488372085,"floatShares":548000000,"shares":548000000,"eps":-0.434858,"marketStatus":"未开盘","change":-0.2,"latestTime":"02-04 16:00:00","open":3.43,"high":3.46,"low":3.23,"amount":3743380,"amplitude":0.06686,"askPrice":3.3,"askSize":5000,"bidPrice":3.25,"bidSize":6000,"shortable":0,"etf":0,"ttmEps":-0.558412,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":1619625600000,"exchange":"SEHK","adjPreClose":3.44,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":0.696815,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06622","defaultTab":"news","newsList":[{"id":"2608518863","title":"李氏大药厂02月04日主力净流出18.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608518863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608518863?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192939,"startTime":"0","endTime":"0","summary":"02月04日, 李氏大药厂股价跌2.63%，报收1.48元，成交金额244.3万元，换手率0.28%，振幅4.61%，量比1.58。李氏大药厂今日主力资金净流出18.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌8.64%，主力资金累计净流出36.0万元；近20日主力资金累计净流出47.6万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161851a47afbd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161851a47afbd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06622","00950","BK1583","BK1587","BK1191"],"gpt_icon":0},{"id":"2609948399","title":"兆科眼科-B02月04日主力净流出25.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609948399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609948399?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192934,"startTime":"0","endTime":"0","summary":"02月04日, 兆科眼科-B股价跌5.81%，报收3.24元，成交金额374.3万元，换手率0.21%，振幅6.69%，量比0.69。兆科眼科-B今日主力资金净流出25.5万元，上一交易日主力净流入59.8万元。该股近5个交易日下跌7.16%，主力资金累计净流入165.9万元；近20日主力资金累计净流入419.3万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161818a47afb31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161818a47afb31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1191","BK1574","BK1583","BK1587"],"gpt_icon":0},{"id":"2608289538","title":"兆科眼科-B盘中异动 股价大跌5.16%报3.490港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608289538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608289538?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:35","pubTimestamp":1770017733,"startTime":"0","endTime":"0","summary":"2026年02月02日临近收盘15时35分，兆科眼科-B股票出现异动，股价急速下跌5.16%。截至发稿，该股报3.490港元/股，成交量92万股，换手率0.17%，振幅5.43%。资金方面，该股资金流入136.771万港元，流出170.779万港元。兆科眼科-B股票所在的药品行业中，整体跌幅为1.32%。其相关个股中，康哲药业、中智药业、励晶太平洋涨幅较大，振幅较大的相关个股有中智药业、康哲药业、石药集团，振幅分别为11.59%、10.48%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202153533953f67a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202153533953f67a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1583","BK1574","BK1587","BK1191"],"gpt_icon":0},{"id":"2607109629","title":"全球首个复方老花眼滴眼液获FDA批准上市，兆科眼科-B(6622.HK)抢占眼科创新赛道先机","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109629","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607109629?lang=zh_cn&edition=full","pubTime":"2026-01-30 14:48","pubTimestamp":1769755720,"startTime":"0","endTime":"0","summary":"兆科眼科宣布，其合作伙伴Tenpoint Therapeutics公司已获得美国FDA监管批准，允许老花眼治疗创新药物BRIMOCHOL™ PF上市销售。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/5.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/5.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3725172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["06622","BK1574","BK1587","BK1583","BK1191"],"gpt_icon":0},{"id":"2607082586","title":"兆科眼科-B(06622)：Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2607082586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607082586?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:36","pubTimestamp":1769690182,"startTime":"0","endTime":"0","summary":"此滴眼液于临床试验期间名为BRIMOCHOL PF，在美国的商用名称将为YUVEZZI，作为用于治疗老花眼的创新药物。此批准在Tenpoint成功完成第3期临床试验后取得。此外，在BRIO II研究监测的逾72000个治疗日中，BRIMOCHOL PF耐受性良好，未观察到治疗相关的严重不良事件。在BRIO II研究中，接受BRIMOCHOL PF的受试者出现眼部充血不良事件的报告率低于单独接受卡巴胆硷的受试者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"兆科眼科-B(06622)：Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1191","06622","BK1574","BK1583"],"gpt_icon":1},{"id":"2607709270","title":"港股兆科眼科-B(06622.HK)盘中涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607709270","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607709270?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:03","pubTimestamp":1769673781,"startTime":"0","endTime":"0","summary":"每经AI快讯，兆科眼科-B(06622.HK)盘中涨超7%，截至发稿，涨3.44%，报3.61港元，成交额1143.15万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601293635223587.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601293635223587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1587","BK4585","BK1191","BK4588","VT","06622","BK1583"],"gpt_icon":0},{"id":"2607709838","title":"港股异动 | 兆科眼科-B(06622)盘中涨超7% 公司扩大与AFT的合作至新加坡 与千寿达成越南合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2607709838","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607709838?lang=zh_cn&edition=full","pubTime":"2026-01-29 15:56","pubTimestamp":1769673400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B盘中涨超7%，截至发稿，涨3.44%，报3.61港元，成交额1143.15万港元。消息面上，1月26日，兆科眼科宣布，将其核心老花眼治疗药物BRIMOCHOL PF在新加坡和越南的独家商业化权利，分别授予新西兰的AFT Pharmaceuticals和日本的千寿制药。至此，兆科眼科其全球化商业版图已延伸至韩国、澳洲、新西兰、泰国、印度尼西亚、台湾地区、新加坡和越南八个市场。根据协议，兆科眼科授予AFT在新加坡、授予千寿在越南的独家分销权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1574","BK1587","BK4585","VT","BK1583","BK1191","06622","AFT"],"gpt_icon":0},{"id":"2606789993","title":"李氏大药厂(00950)：FDA批准《ADASUVE®》的补充新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2606789993","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606789993?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:06","pubTimestamp":1769515574,"startTime":"0","endTime":"0","summary":"智通财经APP讯，李氏大药厂 发布公告，《ADASUVE》的补充新药上市申请已于2025年12月29日获美国食品药品监督管理局批准。取得FDA批准后，位于加州弗里蒙特的生产设施已获授权于美国境内进行《ADASUVE》的商业化生产。NPI取得FDA批准，标志着集团达成关键监管里程碑，亦代表与公司首项美国制药设施收购相关的监管要求已经完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06622","00950","BK1191","BK1587","BK1574"],"gpt_icon":0},{"id":"2606782046","title":"李氏大药厂01月27日主力净流入27.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606782046","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606782046?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501753,"startTime":"0","endTime":"0","summary":"01月27日, 李氏大药厂股价涨0.65%，报收1.56元，成交金额98.3万元，换手率0.11%，振幅1.94%，量比0.87。李氏大药厂今日主力资金净流入27.2万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.64%，主力资金累计净流入6.5万元；近20日主力资金累计净流出80.2万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162307a45b2a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162307a45b2a69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1583","BK1587","BK1574","06622","BK1191"],"gpt_icon":0},{"id":"2606279125","title":"港股异动 | 兆科眼科-B(06622)涨超5% 已扩大与AFT的伙伴协议 于新加坡商业化BRIMOCHOL™ PF","url":"https://stock-news.laohu8.com/highlight/detail?id=2606279125","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606279125?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:02","pubTimestamp":1769482937,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B涨超5%，截至发稿，涨4.56%，报3.44港元，成交额170.7万港元。消息面上，1月26日，兆科眼科-B发布公告，公司已扩大与领先健康护理产品制造商及分销商AFT Pharmaceuticals Limited的伙伴协议，以于新加坡商业化BRIMOCHOL PF。兆科分别授予AFT及千寿于新加坡及越南的独家分销权，当中包括于相关市场注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","AFT","BK1587","06622","BK1191"],"gpt_icon":0},{"id":"2606187862","title":"兆科眼科-B(06622)透过与AFT及千寿建立伙伴关系，推动用于治疗老花眼的BRIMOCHOL™ PF于新加坡及越南的商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2606187862","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606187862?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:47","pubTimestamp":1769417253,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 公布，公司已扩大与领先健康护理产品制造商及分销商AFT Pharmaceuticals Limited的伙伴协议，以于新加坡商业化BRIMOCHOL PF。兆科分别授予AFT及千寿于新加坡及越南的独家分销权，当中包括于相关市场注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。透过该等协议，AFT及千寿成为BRIMOCHOL PF的第七及第八名商业化伙伴，彰显公司进军全球的坚定承诺。于2025年6月，Tenpoint宣布，美国FDA已受理该药品的新药上市申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","AFT","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2604157132","title":"李氏大药厂01月19日主力净流出27.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2604157132","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604157132?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:16","pubTimestamp":1768810566,"startTime":"0","endTime":"0","summary":"01月19日, 李氏大药厂股价跌3.07%，报收1.58元，成交金额154.7万元，换手率0.17%，振幅3.68%，量比0.92。李氏大药厂今日主力资金净流出27.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.25%，主力资金累计净流出23.6万元；近20日主力资金累计净流出171.8万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162627a43c13a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162627a43c13a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1583","BK1574","BK1587","BK1191","00950"],"gpt_icon":0},{"id":"2603646042","title":"兆科眼科-B01月14日获主力加仓90.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646042","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603646042?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:16","pubTimestamp":1768378565,"startTime":"0","endTime":"0","summary":"01月14日, 兆科眼科-B股价涨5.92%，报收3.58元，成交金额516.8万元，换手率0.27%，振幅5.62%，量比1.67。兆科眼科-B今日主力资金净流入90.0万元，上一交易日主力净流入24.6万元。|01月14日主力加仓幅度排名||#|股票简称|主力净额占比|#|PACIFICLEGEND|5.02%|#|飞道旅游科技|1.96%|#|荣尊国际控股|1.75%|#|...|...|#188|兆科眼科-B|0.05%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162452a71953e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162452a71953e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1587","06622","BK1574","BK1583"],"gpt_icon":0},{"id":"2603661197","title":"兆科眼科-B(06622.HK)午后涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603661197","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603661197?lang=zh_cn&edition=full","pubTime":"2026-01-14 13:51","pubTimestamp":1768369867,"startTime":"0","endTime":"0","summary":"每经AI快讯，兆科眼科-B(06622.HK)午后涨超6%，截至发稿涨6.21%，报3.59港元，成交额328.27万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601143618797513.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601143618797513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","BK1191","BK1574","BK1583","06622"],"gpt_icon":0},{"id":"2603711507","title":"兆科眼科-B(06622)：澳洲THERAPEUTIC GOODS ADMINISTRATION（治疗用品管理局）受理评核硫酸阿托品滴眼液的注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2603711507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603711507?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:11","pubTimestamp":1768299065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 发布公告，于2026年1月5日，澳洲Therapeutic Goods Administration已受理评核本公司就其用于治疗儿童近视加深的硫酸阿托品滴眼液提出的注册申请。硫酸阿托品滴眼液乃一项专利配方，成功解决低浓度阿托品的不稳性，此技术在全球均受到知识产权保护。硫酸阿托品滴眼液不含防腐剂，预计保存期逾24个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"1199733972","title":"兆科眼科硫酸阿托品滴眼液获澳大利亚药品管理局受理审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1199733972","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199733972?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:10","pubTimestamp":1768299016,"startTime":"0","endTime":"0","summary":"兆科眼科-B（06622）宣布，其研发的硫酸阿托品滴眼液已正式获得澳大利亚药品管理局（Therapeutic Goods Administration）的审评受理。该产品旨在用于延缓儿童近视进展，此次受理标志着公司在国际化战略布局上迈出重要一步。\n作为眼科创新药研发企业，兆科眼科持续深耕近视防控领域。硫酸阿托品滴眼液若最终获批，将有望为澳大利亚市场提供新的近视管理方案。公司表示将积极配合监管机构开展后续审评工作，推动产品早日惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2603639346","title":"李氏大药厂01月13日主力净流入25.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603639346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603639346?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:16","pubTimestamp":1768292168,"startTime":"0","endTime":"0","summary":"01月13日, 李氏大药厂股价涨1.25%，报收1.62元，成交金额154.4万元，换手率0.16%，振幅2.50%，量比0.96。李氏大药厂今日主力资金净流入25.4万元，上一交易日主力净流出43.4万元。该股近5个交易日上涨2.53%，主力资金累计净流出1.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出102.8万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113163025a714edea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113163025a714edea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","00950","BK1587","06622","BK1191"],"gpt_icon":0},{"id":"2602654517","title":"李氏大药厂01月12日主力净流出43.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602654517","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602654517?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205743,"startTime":"0","endTime":"0","summary":"01月12日, 李氏大药厂股价跌1.84%，报收1.60元，成交金额206.9万元，换手率0.22%，振幅3.68%，量比1.44。李氏大药厂今日主力资金净流出43.4万元，上一交易日主力净流入32.5万元。该股近5个交易日下跌0.62%，主力资金累计净流出26.7万元；近20日主力资金累计净流出214.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162517a4b9bc15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162517a4b9bc15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","06622","00950","BK1574","BK1587"],"gpt_icon":0},{"id":"2601874415","title":"李氏大药厂01月07日主力净流出15.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601874415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601874415?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773753,"startTime":"0","endTime":"0","summary":"01月07日，李氏大药厂股价收平报1.58元，成交金额88.7万元，换手率0.10%，振幅3.16%，量比0.69。李氏大药厂今日主力资金净流出15.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.64%，主力资金累计净流出15.9万元；近20日主力资金累计净流出220.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162138a4a6d5fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162138a4a6d5fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1191","BK1587","06622","BK1574","BK1583"],"gpt_icon":0},{"id":"2601858733","title":"兆科眼科-B盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601858733?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:52","pubTimestamp":1767577972,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘09时52分，兆科眼科-B股票出现异动，股价急速上涨5.05%。截至发稿，该股报3.330港元/股，成交量20.8万股，换手率0.04%，振幅5.05%。兆科眼科-B股票所在的药品行业中，整体跌幅为0.46%。其相关个股中，中智药业、中国同辐、兆科眼科-B涨幅较大，振幅较大的相关个股有宝济药业-B、中智药业、长风药业，振幅分别为11.76%、10.00%、8.54%。该公司在中国国内及海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095252a6f3b8e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095252a6f3b8e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06622","BK1574","BK1191","BK1587"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0716},{"period":"1month","weight":0},{"period":"3month","weight":0.0318},{"period":"6month","weight":-0.1314},{"period":"1year","weight":1.4545},{"period":"ytd","weight":0.0946}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司已建立创新药及仿制药组合，针对影响眼前节及眼后节的六种主要眼科疾病。该等主要眼科适应症为干眼症（DED）、近视、老花眼、湿性老年黄斑部病变（wAMD）/糖尿病黄斑水肿（DME）、青光眼及角膜上皮功能障碍（CED）。该公司的主要产品管线包括NVK002（阿托品）、环孢素A眼凝胶、TAB014（贝伐单抗）等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.147188},{"month":2,"riseRate":0.2,"avgChangeRate":-0.135272},{"month":3,"riseRate":0.25,"avgChangeRate":-0.026625},{"month":4,"riseRate":0.25,"avgChangeRate":0.028543},{"month":5,"riseRate":0.4,"avgChangeRate":0.043975},{"month":6,"riseRate":0.2,"avgChangeRate":0.042663},{"month":7,"riseRate":0.4,"avgChangeRate":-0.054975},{"month":8,"riseRate":0.2,"avgChangeRate":-0.017626},{"month":9,"riseRate":0.6,"avgChangeRate":0.007418},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082811},{"month":11,"riseRate":0.4,"avgChangeRate":0.029799},{"month":12,"riseRate":0.2,"avgChangeRate":-0.018114}],"exchange":"SEHK","name":"兆科眼科-B","nameEN":"ZHAOKE OPHTH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兆科眼科-B,06622,兆科眼科-B股票,兆科眼科-B股票老虎,兆科眼科-B股票老虎国际,兆科眼科-B行情,兆科眼科-B股票行情,兆科眼科-B股价,兆科眼科-B股市,兆科眼科-B股票价格,兆科眼科-B股票交易,兆科眼科-B股票购买,兆科眼科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}